Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Irv Weissman as a Venture Partner. The firm's profile page gives the current affiliation as Director, Stanford Ludwig Center for Cancer Stem Cell Research and Medicine; Professor of Pathology and Developmental Biology, Stanford University. His stated honours include the Wallace H. Coulter Award for Lifetime Achievement in Hematology (2022), the Albany Medical Center Prize (2019), the Charles Rodolphe Brupbacher Prize for Cancer Research (2015) and election to the National Academy of Sciences (1989). Pheast Therapeutics, Inc.'s Form D filed 16 October 2025 lists Irving Weissman as a Director of that issuer.